American Origin Unverified
This profile is unclaimed and has not been independently reviewed.
Claim & get verified
BI
BioStem Technologies, Inc.
$3.68
-5.54%
OTC: BSEM · 15-min delayed
BSEMOTC
About BioStem Technologies, Inc.
BIOSTEM TECHNOLOGIES NEW
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
Market data by Polygon.io · prices are 15-minute delayed
Auto-generated
At a glance
- Trading 76% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review BioStem Technologies, Inc..
Write a review
Newsroom
News about BioStem Technologies, Inc.
BioStem Technologies to Present at the 46th Annual TD Cowen Healthcare Conference
BioStem Technologies Advances Entry into the Acute Wound Care Market with Acquisition of BioTissue Holdings' Surgical and Wound Care Business
BioStem Technologies® to Debut American Amnion™ at the 2025 Desert Foot Multi-Disciplinary Limb Salvage and Wound Care Conference
BioStem Technologies Reports Positive Top-Line Clinical Results Demonstrating Superior Outcomes with BioRetain® Allograft in Diabetic Foot Ulcers
BioStem Technologies Expands Partnership with the Florida Panthers as a Sponsor for the 13th Season of the “Heroes Among Us” Program
North America Diabetic Foot Ulcer Treatment Market Rises at 5.74% CAGR by 2034
News & sentiment via Polygon.io
Explore
Browse all →
